Startups
2014
ADVANCED BRAIN COMPANION DIAGNOSTICS SPAIN SL (ABCDX)Point-of-care biomarkers transforming the management of brain-injured patients
Address
Carrer de Sant Antoni Maria Claret 167, 08025 Barcelona, Spain
CERCA ownership
Barcelona, Spain
2002
Vall d’Hebron Institut de Recerca (VHIR)
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
ABCDx pursues an innovative business approach to take part in the digital health revolution with the development of a Patient-Management App that can ensure the control over the use of its technologies and provide additional benefits to the healthcare professionals for the management of its patients.
Specialized in the discovery, clinical validation and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for brain injuries
ABCDx develops a portfolio of diagnostic tools for brain diseases. The most advanced programme is TBI check, a user-friendly diagnostic test, allowing Health care professionals (HCPs), Sport & military organizations to better detect patients with mild traumatic brain injury (TBI).
Specialized in the discovery, clinical validation and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for brain injuries
ABCDx develops a portfolio of diagnostic tools for brain diseases. The most advanced programme is TBI check, a user-friendly diagnostic test, allowing Health care professionals (HCPs), Sport & military organizations to better detect patients with mild traumatic brain injury (TBI).
Product description
Mild Traumatic Brain Injury (mTBI) is a major consequence of head c oncussion. mTBI can result in long-term complications or death. It affects 3 million people per year in Europe [1], mostly children, elderly, sportsmen and military forces who have the higher incidence.
With a drop of blood from a finger prick at the point of care, TBICheck™ allows to rapidly discharge patients with a suspected brain injury.
TBICheck™ can avoid the CT-scan for approximately half of the traumatic brain injury patients by improving patients’ triage, thus reducing the burden for patients and decreasing healthcare costs.
The solution STROKECheck
A wide-available rapid biochemical test would add advantages in the pre-hospital triage and management of stroke patients, allowing to begin time limited treatment options as reperfusion therapies (i.e. tPA treatment) at the admission or event at the ambulance and therefore improving enormously the rates of recovery of ischemic stroke patients
The solution COMPLICheck
ABCDx biomarker panel offers the potential of a more tailored approach to preventive antibiotic therapy using blood biomarkers that identify patients at a high risk of post-brain injury infections, reducing this risk and increasing the efficacy of antibiotic therapy by allowing treatments to be implemented more rapidly on patients at risk.
The solution BRAINCheck App
ABCDx detains the know-how and can provide the algorithm in a software for smartphone of tablet. The App that takes in all the available patient information and reports the assessment based on an ABCDx-owned database.
With a drop of blood from a finger prick at the point of care, TBICheck™ allows to rapidly discharge patients with a suspected brain injury.
TBICheck™ can avoid the CT-scan for approximately half of the traumatic brain injury patients by improving patients’ triage, thus reducing the burden for patients and decreasing healthcare costs.
The solution STROKECheck
A wide-available rapid biochemical test would add advantages in the pre-hospital triage and management of stroke patients, allowing to begin time limited treatment options as reperfusion therapies (i.e. tPA treatment) at the admission or event at the ambulance and therefore improving enormously the rates of recovery of ischemic stroke patients
The solution COMPLICheck
ABCDx biomarker panel offers the potential of a more tailored approach to preventive antibiotic therapy using blood biomarkers that identify patients at a high risk of post-brain injury infections, reducing this risk and increasing the efficacy of antibiotic therapy by allowing treatments to be implemented more rapidly on patients at risk.
The solution BRAINCheck App
ABCDx detains the know-how and can provide the algorithm in a software for smartphone of tablet. The App that takes in all the available patient information and reports the assessment based on an ABCDx-owned database.